Press release
Endometrial Cancer Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Abbott Laboratories, Inc., ARIAD Pharmaceuticals
DelveInsight's "Endometrial Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Endometrial Cancer, historical and forecasted epidemiology as well as the Endometrial Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Endometrial Cancer market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Endometrial Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Endometrial Cancer Market Insights
https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Endometrial Cancer Market Report:
• The Endometrial Cancer market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In July 2023, AstraZeneca announced encouraging top-line findings from the DUO-E trial (GOG 3041/ENGOT-EN10) involving the use of Imfinzi (durvalumab) combined with platinum-based chemotherapy, followed by either Imfinzi with Lynparza (olaparib) or Imfinzi alone as maintenance therapy in patients with advanced or recurrent endometrial cancer.
• According to the National Cancer Institute, approximately 3 in 100 women will be diagnosed with uterine cancer at some point in their lives
• 80 percent of people with uterine cancer survive for five years or longer after receiving the diagnosis. Endometrial cancer comprises about 4% of all cancers in women globally
• According to the American cancer society, in the United States, the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs
• As per Cancer Research UK, there are around 9,700new uterine cancer cases in the UK every year, that is 27 every day (2016-2018). Among females in the UK, uterine cancer is the 4th most common cancer,with around 9,700 new cases in 2017
• According to the study by Aoki et al. ) 2020), about 380 000 new cases of endometrial cancer occur every year in the world, and about 89,000 deaths are confirmed annually. Endometrial cancer is the 10th most common cause of cancer in women in Japan, with more than 14,900 new patients diagnosed per year in recent years
• Key Endometrial Cancer Companies: AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Abbott Laboratories, Inc., ARIAD Pharmaceuticals, Inc., Becton, Dickinson and Company, F. Hoffmann, La Roche AG, GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG. Siemens Healthineers, and others
• Key Endometrial Cancer Therapies: Lynparza (Olaparib) + Imfinzi DuO-E, Selinexor, EG-007, and others
Endometrial Cancer Overview
The Endometrial Cancer Market refers to the commercial landscape surrounding the diagnosis, treatment, and management of endometrial cancer, a type of cancer that originates in the lining of the uterus, known as the endometrium. This market encompasses a wide range of products and services, including diagnostic tests, surgical procedures, chemotherapy drugs, hormonal therapies, radiation therapy, and supportive care interventions.
Get a Free sample for the Endometrial Cancer Market Report:
https://www.delveinsight.com/report-store/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Endometrial Cancer Market
The dynamics of the Endometrial Cancer market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
Endometrial Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Endometrial Cancer Epidemiology Segmentation:
The Endometrial Cancer market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Endometrial Cancer
• Prevalent Cases of Endometrial Cancer by severity
• Gender-specific Prevalence of Endometrial Cancer
• Diagnosed Cases of Episodic and Chronic Endometrial Cancer
Download the report to understand which factors are driving Endometrial Cancer epidemiology trends @ Endometrial Cancer Epidemiological Insights
https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Endometrial Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Endometrial Cancer market or expected to get launched during the study period. The analysis covers Endometrial Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Endometrial Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
To know more about Endometrial Cancer treatment, visit @ Endometrial Cancer Medications
https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Endometrial Cancer Therapies and Key Companies
• Lynparza (Olaparib) + Imfinzi DuO-E: AstraZeneca
• Selinexor: Karyopharm Therapeutics
• EG-007: Evergreen Therapeutics
Endometrial Cancer Market Drivers
• Rising cases of the disease
• Increasing cases of various risk Factors
• Sedentary Lifestyle and Socio-economic Factors
Endometrial Cancer Market Barriers
• Side effects of therapies
• Economic Burden
• High toxicity of drugs
Scope of the Endometrial Cancer Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Endometrial Cancer Companies: AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Abbott Laboratories, Inc., ARIAD Pharmaceuticals, Inc., Becton, Dickinson and Company, F. Hoffmann, La Roche AG, GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG. Siemens Healthineers, and others
• Key Endometrial Cancer Therapies: Lynparza (Olaparib) + Imfinzi DuO-E, Selinexor, EG-007, and others
• Endometrial Cancer Therapeutic Assessment: Endometrial Cancer current marketed and Endometrial Cancer emerging therapies
• Endometrial Cancer Market Dynamics: Endometrial Cancer market drivers and Endometrial Cancer market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Endometrial Cancer Unmet Needs, KOL's views, Analyst's views, Endometrial Cancer Market Access and Reimbursement
Discover more about therapies set to grab major Endometrial Cancer market share @ Endometrial Cancer market forecast
https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Endometrial Cancer Market Report Introduction
2. Executive Summary for Endometrial Cancer
3. SWOT analysis of Endometrial Cancer
4. Endometrial Cancer Patient Share (%) Overview at a Glance
5. Endometrial Cancer Market Overview at a Glance
6. Endometrial Cancer Disease Background and Overview
7. Endometrial Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Endometrial Cancer
9. Endometrial Cancer Current Treatment and Medical Practices
10. Endometrial Cancer Unmet Needs
11. Endometrial Cancer Emerging Therapies
12. Endometrial Cancer Market Outlook
13. Country-Wise Endometrial Cancer Market Analysis (2019-2032)
14. Endometrial Cancer Market Access and Reimbursement of Therapies
15. Endometrial Cancer Market Drivers
16. Endometrial Cancer Market Barriers
17. Endometrial Cancer Appendix
18. Endometrial Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Endometrial Cancer Pipeline https://www.delveinsight.com/report-store/endometrial-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Endometrial Cancer Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Endometrial Cancer market. A detailed picture of the Endometrial Cancer pipeline landscape is provided, which includes the disease overview and Endometrial Cancer treatment guidelines.
Endometrial Cancer Epidemiology https://www.delveinsight.com/report-store/endometrial-cancer-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Endometrial Cancer Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Endometrial Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Graft Versus Host Disease Market https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
DelveInsight's "Graft Versus Host Disease (GvHD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graft Versus Host Disease, historical and forecasted epidemiology as well as the Graft Versus Host Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
DelveInsight's "Asthma - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
DelveInsight's "Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myelodysplastic Syndrome, historical and forecasted epidemiology as well as the Myelodysplastic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endometrial Cancer Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Abbott Laboratories, Inc., ARIAD Pharmaceuticals here
News-ID: 3479606 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Endometrial
Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Canc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Endometrial Cancer Treatment Industry Market Size Be by 2025?
In recent years, the market size for endometrial cancer treatment has experienced consistent growth. It is projected to increase from $31.04 billion in 2024 to $32.09 billion in 2025, indicating a compound annual growth rate (CAGR) of…
Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Canc …
The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Endometrial Cancer Treatment Market Size and Projected Growth Rate?
The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to…
Endometrial Biopsy Cannulae Market 2023
The report presents detailed information regarding the prominent players and potential competitors in the Endometrial Biopsy Cannulae market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player.
This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue, growth…
Hysteroscopic Endometrial Resection Market - Transforming Hysteroscopy, Enhancin …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Hysteroscopic Endometrial Resection Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Hysteroscopic Endometrial Resection provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes…
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot
With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world.
Download The…
Global Endometrial Ablation Market: Radiofrequency Endometrial Ablation Devices …
With the presence of large players, such as Hologic Corp., Boston Scientific Corp., Cooper Surgical Inc., Ethicon Inc., and Medtronic Plc at the global level, the worldwide market for endometrial ablation demonstrates a highly competitive landscape, finds a new research report by Transparency Market Research (TMR).
The market players are focusing aggressively on developing their offerings technologically, which is likely to lead to price differentiation, resulting in intense rivalry between these…
